Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
04/05/2012 | WO2012040923A1 Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases |
04/05/2012 | WO2012040845A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process |
04/05/2012 | US20120083607 Enzymatic Transamination of Cyclopamine Analogs |
04/05/2012 | US20120083557 Sterically hindered amine stabilizers |
04/05/2012 | US20120083501 Compounds for treating neurodegenerative diseases |
04/05/2012 | US20120083488 Tetracyclic compound |
04/05/2012 | US20120083484 Cyclopamine lactam analogs and methods of use thereof |
04/05/2012 | CA2811465A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process |
04/05/2012 | CA2811192A1 1,2,4-triazolone derivative |
04/05/2012 | CA2811033A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
04/04/2012 | EP2435440A1 New spiroheterocyclic furan and thiofuran dione derivatives |
04/04/2012 | EP2435438A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use |
04/04/2012 | EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions |
04/04/2012 | EP2097420B1 Spiroketone inhibitors of acetyl-coa carboxylase |
04/04/2012 | EP1338336B1 Use of catalysts comprising n-substituted cyclic imides for preparing organic compounds |
04/04/2012 | CN102399231A 加兰他敏制备方法 Galantamine preparation |
04/04/2012 | CN102399230A N-酰基吡唑鱼藤醚及其制备方法与应用 N- acyl pyrazole rotenone ethers and their preparation method and application |
04/04/2012 | CN102399229A N-酰基吡唑鱼藤酚及其制备方法与应用 N- acyl pyrazole rotenone phenol and its preparation method and application |
04/04/2012 | CN102399228A N-烷基多羟基哌啶衍生物的制备方法 Preparation of N- alkyl polyhydroxy piperidine derivatives |
04/03/2012 | US8148554 Methods and compositions for use in treating cancer |
04/03/2012 | US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
04/03/2012 | US8148529 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof |
04/03/2012 | US8148413 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
04/03/2012 | US8148395 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
04/03/2012 | US8148390 Monocyclic anilide spirolactam CGRP receptor antagonists |
04/03/2012 | US8148388 2,4 (4,6) pyrimidine derivatives |
04/03/2012 | US8148370 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof |
04/03/2012 | US8147809 Soft anticholinergic esters |
04/03/2012 | CA2674369C Fused substituted aminopyrrolidine derivative |
04/03/2012 | CA2493329C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
03/29/2012 | WO2012040641A2 Compounds for treating neurodegenerative diseases |
03/29/2012 | WO2012039561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
03/29/2012 | WO2012038975A2 Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof |
03/29/2012 | WO2011116282A3 Nicotinic acetylcholine receptor agonists |
03/29/2012 | US20120077802 Histamine h3 inverse agonists and antagonists and methods of use thereof |
03/29/2012 | US20120077778 Ladder-Frame Polyether Conjugates |
03/29/2012 | US20120077678 Substituted Pyrazine (Thio)Pyrans with a Herbicidal Action |
03/28/2012 | EP2433938A1 Therapeutic agent for motor disorders |
03/28/2012 | EP2432785A1 Herbicidal spiroheterocyclic tetronic acid derivatives |
03/28/2012 | EP2432783A1 Modulators of 5-ht receptors and methods of use thereof |
03/28/2012 | EP1951690B1 Heterocyclic cetp inhibitors |
03/28/2012 | EP1603883B1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
03/28/2012 | EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
03/28/2012 | CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1 |
03/28/2012 | CN102391292A Polyamine copper complexes using rhodamine B as fluorescent marker and method for detecting nitric oxide by using polyamine copper complexes |
03/28/2012 | CN102391273A Method for extracting deltaline from white baneberry |
03/28/2012 | CN102391272A 1,4-disubstituent-1,4-dihydrobenzopranyl [4,3-c] pyrazole compounds |
03/28/2012 | CN102391266A Method for extracting and separating pseudolycorine from lycoris plants |
03/28/2012 | CN101928264B Apoptosis promoters |
03/28/2012 | CN101838273B Method for extracting strychnine from semen strychni |
03/28/2012 | CN101391999B Method for preparing dehydration tetrodotoxin high purity monomer |
03/27/2012 | US8143304 (3-amino-1,2,3,4-tetrahydro-9 H-carbazol-9-yl)-acetic acid derivatives |
03/27/2012 | US8143271 Compounds and methods for kinase modulation, and indications therefor |
03/27/2012 | US8142784 Antibody-drug conjugates and methods |
03/22/2012 | WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
03/22/2012 | WO2012035934A1 Organic electroluminescent element |
03/22/2012 | WO2012035853A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device |
03/22/2012 | WO2012035023A1 Triazine-oxadiazoles |
03/22/2012 | US20120071657 Triazole compounds useful as protein kinase inhibitors |
03/22/2012 | US20120071319 Spiroheterocyclic furan and thiofuran dione derivatives |
03/22/2012 | US20120068170 Materials for organic electroluminescent devices |
03/22/2012 | CA2812081A1 Triazine-oxadiazoles |
03/22/2012 | CA2811080A1 Heterocyclic compound |
03/21/2012 | EP2431361A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof |
03/21/2012 | EP2430015A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases |
03/21/2012 | EP2429993A1 Inhibitors of human immunodeficiency virus replication |
03/21/2012 | EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
03/21/2012 | EP1771450B9 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
03/21/2012 | CN102388052A Spiro derivatives for the modulation of stearoyl-CoA desaturase |
03/21/2012 | CN102388051A Inhibitors of HIV replication |
03/21/2012 | CN102388034A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
03/21/2012 | CN102382129A Spirocycles-substituted phosphodiesterase inhibitor |
03/21/2012 | CN102382119A Extraction method of tetrandrine and demethyltetrandrine |
03/21/2012 | CN102382063A 6-amino-5-cyano-pyrimidine-4-ones compound used for improving perception, power of concentration, learning efficiency, and/or memory power |
03/21/2012 | CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity |
03/20/2012 | US8138344 Process for the preparation of rapamycin derivatives |
03/20/2012 | US8138343 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
03/20/2012 | US8138206 Piperidine derivative |
03/20/2012 | US8138194 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
03/20/2012 | US8138171 Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
03/20/2012 | CA2509139C Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
03/20/2012 | CA2505029C Isoindoline derivatives |
03/15/2012 | WO2012031563A1 Heterocyclic amino berbamine derivatives, preparation method and use thereof |
03/15/2012 | WO2011147951A8 Cycloamino derivatives as gpr119 agonists |
03/15/2012 | WO2011133659A3 Inhibitors of hif and angiogenesis |
03/15/2012 | US20120065400 Transfer Hydrogenation of Cyclopamine Analogs |
03/15/2012 | US20120065399 Transfer Hydrogenation of Cyclopamine Analogs |
03/15/2012 | US20120065226 Salts of tiotropium with 10-camphorsulfonic acid |
03/15/2012 | US20120065223 Solid forms of a chemokine receptor antagonist and methods of use thereof |
03/15/2012 | US20120065219 Spirocyclic azaadamantane derivatives and methods of use |
03/15/2012 | US20120065218 Heterocyclic Cyclopamine Analogs and Methods of Use Thereof |
03/15/2012 | US20120065195 Compounds for treating neurodegenerative diseases |
03/15/2012 | US20120065191 Pharmaceutical compounds |
03/15/2012 | US20120065162 N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
03/14/2012 | EP2428586A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
03/14/2012 | EP2428508A1 Diamino heterocyclic carboxamide compound |
03/14/2012 | EP2427450A1 Gpr 119 modulators |
03/14/2012 | EP2427448A1 Gpr 119 modulators |
03/14/2012 | EP1971608B1 Spiroketals |
03/14/2012 | EP1474420B1 Quinazoline compounds |